TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32209328

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 500 μM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 5 mM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 500 μM in RNCMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 5 mM in RNCMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) 5 mM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with NR 0.35%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with NR 1.0%
Number of subjects: 0
Study: 34887466

Group type: EXPERIMENTAL
Intervention: Drinking liquid food after tasting
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Adding chewing while tasting
Number of subjects: 11

Group type: COMPARATOR
Intervention: Drinking liquid food normally
Number of subjects: 11
Study: 34198100

Group type: EXPERIMENTAL
Intervention: Feed-forward artificial neural network (ANN) model
Number of subjects: 1412
Study: 32068562

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 35460868

Group type: EXPERIMENTAL
Intervention: Vaginal delivery (VD)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Labor duration
Number of subjects: 462
Study: 33242299

Group type: EXPERIMENTAL
Intervention: Dynamic Resistance Training (DRT)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Isometric Resistance Training (IRT)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 193
Study: 35727582

Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvesting (EVH)
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Open vein harvesting (OVH)
Number of subjects: 1150
Study: 34607088

Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32507157

Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise followed by resistance exercise (AR)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resistance exercise followed by combined aerobic exercise (RA)
Number of subjects: 15
Study: 35523495

Group type: EXPERIMENTAL
Intervention: Transdermal electrical stimulation (TdES) with skin electrodes
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 50
Study: 33962185

Group type: EXPERIMENTAL
Intervention: Theme game-based teaching
Number of subjects: 104

Group type: COMPARATOR
Intervention: Multi-station disaster simulation
Number of subjects: 104
Study: 34628013

Group type: EXPERIMENTAL
Intervention: Interdisciplinary palliative care (PC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 150
Study: 32332490

Group type: EXPERIMENTAL
Intervention: PHAB accreditation
Number of subjects: 1329

Group type: COMPARATOR
Intervention: PHAB-accredited states
Number of subjects: 1329
Study: 33466200

Group type: EXPERIMENTAL
Intervention: ABRS granules
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 32124469

Group type: EXPERIMENTAL
Intervention: Continuous-flow portable oxygen concentrator (cPOC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pulsed-flow portable oxygen concentrator (pPOC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (alternative POC)
Number of subjects: 26
Study: 33580809

Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT) daily from inclusion to the day of surgery
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (no PFMT)
Number of subjects: 159
Study: 35166373

Group type: EXPERIMENTAL
Intervention: Oral paracetamol (0.6 ml.kg‐1, 24 mg.ml‐1 concentration)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Water alone (3.6 ml.kg‐1)
Number of subjects: 97
Study: 33710926

Group type: COMPARATOR
Intervention: Inflammatory condition (INF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both conditions (CON and INF)
Number of subjects: 16
Study: 36200545

Group type: EXPERIMENTAL
Intervention: Percutaneous treatment (35.0% in 2020 vs. 25.9% in 2019; p < 0.0001)
Number of subjects: 2498

Group type: EXPERIMENTAL
Intervention: Surgical referral (3.7% in 2020 vs. 4.9% in 2019; p = 0.0001)
Number of subjects: 2498

Group type: EXPERIMENTAL
Intervention: New York Heart Association (NYHA) class IV for heart failure
Number of subjects: 2498

Group type: COMPARATOR
Intervention: Hospitalization outcomes
Number of subjects: 2498
Study: 33895103

Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 32795341

Group type: EXPERIMENTAL
Intervention: Biosimilars to etanercept, infliximab, and adalimumab (SB4, SB2, SB5)
Number of subjects: 1371

Group type: EXPERIMENTAL
Intervention: Baseline predictors (SJC28, CRP, PhGA)
Number of subjects: 1371
Study: 35145311

Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine
Number of subjects: 832

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 832
Study: 34857215

Group type: EXPERIMENTAL
Intervention: Probiotic drink with Lactobacillus strains for 8 weeks
Number of subjects: 50
Study: 33261932

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray combined with a new oral antidepressant (AD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo combined with a new oral antidepressant (AD)
Number of subjects: 0
Study: 32456999

Group type: EXPERIMENTAL
Intervention: Professional attire
Number of subjects: 123

Group type: COMPARATOR
Intervention: Scrubs
Number of subjects: 123
Study: 35858589

Group type: EXPERIMENTAL
Intervention: Anlotinib plus TQB2450
Number of subjects: 34
Study: 33780173

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 32838762

Group type: EXPERIMENTAL
Intervention: Educational video on weight-related conversations
Number of subjects: 57
Study: 36277008

Group type: EXPERIMENTAL
Intervention: Xiyanping
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 86
Study: 33721974

Group type: EXPERIMENTAL
Intervention: Internet-based lifestyle modification (LSM) program
Number of subjects: 415

Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 415
Study: 32384461

Group type: EXPERIMENTAL
Intervention: NKCE
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: NK
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 36011556

Group type: EXPERIMENTAL
Intervention: Multicomponent social support intervention (Exercise Methods and Wellness Knowledge Guide leaflet three times a week)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Control group (no changes required)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Multicomponent social support intervention
Number of subjects: 366
Study: 32199245

Group type: EXPERIMENTAL
Intervention: Perspective-shifting
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Passive sentences
Number of subjects: 56
Study: 35094649

Group type: EXPERIMENTAL
Intervention: Stretching exercise plus dry needling
Number of subjects: 37

Group type: COMPARATOR
Intervention: Stretching exercise only
Number of subjects: 37
Study: 33789133

Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 76

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 76
Study: 33275751

Group type: EXPERIMENTAL
Intervention: Iron supplementation at the time of measles vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 35882525

Group type: EXPERIMENTAL
Intervention: Non-sterile gloves and dressings
Number of subjects: 1480

Group type: COMPARATOR
Intervention: Sterile gloves, dressings and drapes
Number of subjects: 1480
Study: 34705986

Group type: EXPERIMENTAL
Intervention: Single Bond Universal/Filtek Z350XT (SBU)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Selective enamel conditioning (E-SBU)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cements (RMGIC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ethylenediaminetetraacetic acid pretreatment (EDTA; E-RMGIC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SBU
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SE-SBU
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study: 33103448

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 28
Study: 33259829

Group type: EXPERIMENTAL
Intervention: High-protein breakfast (HP)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High-carbohydrate breakfast (HC)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Curtailed sleep (CS)
Number of subjects: 27
Study: 32756846

Group type: EXPERIMENTAL
Intervention: Chemical weeding treatments
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diagrammatic scoring scale
Number of subjects: 50
Study: 35074278

Group type: EXPERIMENTAL
Intervention: Implementation intervention to increase teacher scheduling of physical activity
Number of subjects: 2485

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 2485

Group type: EXPERIMENTAL
Intervention: Implementation intervention
Number of subjects: 2485
Study: 32394019

Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 559

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 559
Study: 32548877

Group type: EXPERIMENTAL
Intervention: CNN-generated candidate beams
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heuristic candidate beams
Number of subjects: 0
Study: 34977994

Group type: EXPERIMENTAL
Intervention: Clinical pharmacy practice model
Number of subjects: 5

Group type: COMPARATOR
Intervention: Usual care process (Control)
Number of subjects: 5
Study: 33354815

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg intravenous subdissociative ketamine (low dose)
Number of subjects: 98

Group type: COMPARATOR
Intervention: 0.30 mg/kg intravenous subdissociative ketamine (high dose)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both doses
Number of subjects: 98
Study: 35280748

Group type: EXPERIMENTAL
Intervention: Whole-course enteral nutrition management
Number of subjects: 222

Group type: COMPARATOR
Intervention: Unsystematic nutrition without setting intake goals for energy and protein
Number of subjects: 222
Study: 32267168

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Mindfulness-based therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 35
Study: 36180944

Group type: EXPERIMENTAL
Intervention: Liver transplantation (LT) + best established treatment (BET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best established treatment (BET) only
Number of subjects: 0
Study: 33842832

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 32840891

Group type: EXPERIMENTAL
Intervention: Web-based Genomic Nursing Education Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard web-based nursing education (Control)
Number of subjects: 0
Study: 35015083

Group type: EXPERIMENTAL
Intervention: Early dinner timing (4 hours prior to habitual bedtime)
Number of subjects: 845

Group type: COMPARATOR
Intervention: Late dinner timing (1 hour prior to habitual bedtime)
Number of subjects: 845
Study: 33058886

Group type: EXPERIMENTAL
Intervention: SLC-ESD (spring-and-loop with clip traction-assisted endoscopic submucosal dissection)
Number of subjects: 80

Group type: COMPARATOR
Intervention: C-ESD (conventional endoscopic submucosal dissection)
Number of subjects: 80
Study: 32064640

Group type: EXPERIMENTAL
Intervention: Karydakis technique (KT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: PE/laser ablation technique (PE + LAT)
Number of subjects: 58
Study: 35925708

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 158
Study: 33432790

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 86
Study: 32430452

Group type: EXPERIMENTAL
Intervention: Adapted physical exercises
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual physical activity (control group)
Number of subjects: 80
Study: 34624138

Group type: EXPERIMENTAL
Intervention: Myo-inositol and d-chiro-inositol combination (MI + DCI) 550 + 150 mg, twice a day for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Combined hormonal contraceptive (CHC) (ethinyl estradiol 20 µg + drospirenone 3 mg), once a day for 6 months
Number of subjects: 70
Study: 34310202

Group type: EXPERIMENTAL
Intervention: EBRT plus AS (Androgen Suppression)
Number of subjects: 481

Group type: COMPARATOR
Intervention: EBRT (Control)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: EBRT plus AS
Number of subjects: 481
Study: 32703216

Group type: EXPERIMENTAL
Intervention: AA mixture containing 1.8 g of arginine, 1.1 g of valine, and 0.1 g of serine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32271637

Group type: EXPERIMENTAL
Intervention: Oral isotretinoin alone at a dose of 0.3 mg/kg/day
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Candida antigen alone at a dose of 0.1 ml of 1/1000 solution into the largest wart
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combination of Candida antigen and oral isotretinoin by the same method and dose
Number of subjects: 108
Study: 32621325

Group type: EXPERIMENTAL
Intervention: Elagolix (oral gonadotropin-releasing hormone antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elagolix (various doses)
Number of subjects: 0
Study: 33187759

Group type: EXPERIMENTAL
Intervention: Interim methadone treatment plus patient navigation (IM + PN)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Interim methadone treatment (IM)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Enhanced Treatment-as-Usual (ETAU)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 225
Study: 35679902

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined HA and PRP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All treatment groups (HA, PRP, HA+PRP)
Number of subjects: 30
Study: 34409891

Group type: EXPERIMENTAL
Intervention: HAD-B1 (972 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: HAD-B1 (1944 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 14
Study: 34465477

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 34668596

Group type: EXPERIMENTAL
Intervention: sacubitril-valsartan
Number of subjects: 376

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 376
Study: 32246262

Group type: EXPERIMENTAL
Intervention: Test meals (beef, pork, chicken) consumed by healthy volunteers in the RCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet with high or moderate protein levels followed by overweight participants in the PREVIEW study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of biomarkers including carnosine
Number of subjects: 0
Study: 32870712

Group type: EXPERIMENTAL
Intervention: Minodronate
Number of subjects: 3896

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 3896
Study: 35679949

Group type: EXPERIMENTAL
Intervention: CDED+PEN
Number of subjects: 80

Group type: COMPARATOR
Intervention: EEN
Number of subjects: 80
Study: 33667228

Group type: EXPERIMENTAL
Intervention: Low self-rated health (SRH)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Intermediate self-rated health (SRH)
Number of subjects: 350

Group type: COMPARATOR
Intervention: High self-rated health (SRH)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Self-rated health (SRH)
Number of subjects: 350
Study: 36162887

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) with diode laser (980 nm, 100 mW for 1 minute)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo LLLT (Control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 30
Study: 32996020

Group type: EXPERIMENTAL
Intervention: Mutation-positive patients (ATM, CHEK2, PALB2)
Number of subjects: 145
Study: 35716046

Group type: EXPERIMENTAL
Intervention: Statin pretreatment
Number of subjects: 1192

Group type: COMPARATOR
Intervention: No statin pretreatment
Number of subjects: 1192
Study: 33986125

Group type: EXPERIMENTAL
Intervention: Ipilimumab administered immediately after sipuleucel-T
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ipilimumab administered delayed 3 weeks after sipuleucel-T
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combination treatment of sipuleucel-T and ipilimumab
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prior localized radiation therapy (RT)
Number of subjects: 50
Study: 35815700

Group type: EXPERIMENTAL
Intervention: Likert scoring
Number of subjects: 791

Group type: COMPARATOR
Intervention: PI-RADS scoring
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Likert tool
Number of subjects: 791
Study: 34535469

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 13157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13157
Study: 34969423

Group type: EXPERIMENTAL
Intervention: Integrated intervention using behavioural counselling with nicotine replacement therapy (NRT) gum
Number of subjects: 100

Group type: COMPARATOR
Intervention: Behavioural counselling alone
Number of subjects: 100
Study: 32448164

Group type: EXPERIMENTAL
Intervention: Deep Inspiration Breath-Hold (DIBH) technique
Number of subjects: 210

Group type: COMPARATOR
Intervention: Free Breathing (FB) technique
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: DIBH-RT for non-smokers
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: DIBH-RT for smokers
Number of subjects: 210
Study: 35956334

Group type: EXPERIMENTAL
Intervention: Omija extract and soybean mixture (OSM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34444773

Group type: EXPERIMENTAL
Intervention: Sunflower oil (SFO)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Heavy cream (HC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fish oil (FO)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Olive oil (OO)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FSO)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: All fat sources
Number of subjects: 23
Study: 33900154

Group type: EXPERIMENTAL
Intervention: High FIS and trained therapists
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low FIS and untrained therapists
Number of subjects: 45
Study: 33318118

Group type: EXPERIMENTAL
Intervention: Complex intervention including 'Stop and Watch' early warning tool, condition-specific care pathway, and communication enhancement tools.
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 245
Study: 36128612

Group type: EXPERIMENTAL
Intervention: Telephone-delivered Behavioral Activation with Mental Imagery (BA-MI)
Number of subjects: 38
Study: 34836276

Group type: EXPERIMENTAL
Intervention: High avocado allotment (14/week/family)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Low avocado allotment (3/week/family)
Number of subjects: 72
Study: 32030887

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily until disease progression
Number of subjects: 9
Study: 36128694

Group type: EXPERIMENTAL
Intervention: SAFETY-A
Number of subjects: 105

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 105
Study: 33428640

Group type: EXPERIMENTAL
Intervention: Measles Supplementary Immunization Activity (SIA)
Number of subjects: 476
Study: 32756160

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 35433551

Group type: EXPERIMENTAL
Intervention: Behavioral guidance intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: Routine pediatric care
Number of subjects: 99
Study: 33404637

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 35089218

Group type: EXPERIMENTAL
Intervention: Febuxostat 40 mg daily before contrast agent and hydration
Number of subjects: 202

Group type: COMPARATOR
Intervention: Hydration only (Control)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Febuxostat combined with hydration
Number of subjects: 202
Study: 32824920

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 8
Study: 35527585

Group type: EXPERIMENTAL
Intervention: Real-ctDCS + task-oriented training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham-ctDCS + task-oriented training
Number of subjects: 16
Study: 33685500

Group type: EXPERIMENTAL
Intervention: Salvianolate 200 mg intravenously dripped for 30 min and then for 7 days
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Salvianolate 200 mg
Number of subjects: 78
Study: 33120356

Group type: EXPERIMENTAL
Intervention: 10‐minute ice massage prior to iontophoresis treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: No pretreatment ice massage (control group)
Number of subjects: 24
Study: 33895362

Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (BUD-FORM) 200/6 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: BUD maintenance 200 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: As-needed terbutaline 0.5 mg
Number of subjects: 0
Study: 32589686

Group type: EXPERIMENTAL
Intervention: 3xDNA plus 1xNYVAC (weeks 0, 4, 8 plus 24; n = 74)
Number of subjects: 147

Group type: COMPARATOR
Intervention: 2xDNA plus 2xNYVAC (weeks 0, 4 plus 20, 24; n = 73)
Number of subjects: 147
Study: 34864483

Group type: EXPERIMENTAL
Intervention: Game-based mobile application (experimental group)
Number of subjects: 154

Group type: COMPARATOR
Intervention: No additional intervention (control group)
Number of subjects: 154